<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="936">
  <stage>Registered</stage>
  <submitdate>12/12/2005</submitdate>
  <approvaldate>14/12/2005</approvaldate>
  <actrnumber>ACTRN12605000789662</actrnumber>
  <trial_identification>
    <studytitle>Post Discharge Care for High-Risk Psychiatric Patients</studytitle>
    <scientifictitle>Post Discharge Care for High Risk Psychiatric Patients: A randomised control trial to evaluate the impact of Intensive Case Management as an Aftercare Intervention in Suicide Attempters Following Discharge from Inpatient Settings to prevent repetition of suicidal behaviour.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Suicide attempts
psychiatric</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Suicide</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants are assigned the Intensive Case Management (ICM) group who will receive the proposed service. Participants in both the ICM (intervention) and TAU (control) groups are to be assessed at 6-month intervals (immediately following discharge, and at 6 and 12 months).  The Project will run for 21 months.  However, timing of Project phases will vary depending on the timing of discharge for participants.</interventions>
    <comparator>Participants are assigned to the Treatment As Usual (TAU) group who will be discharged in the usual way.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Assessments cover the following indicators: Psychopathology, Suicidality, Depression, Hopelessness, Anxiety, Impulsiveness, Reasons for Living, Quality of Life, Global Functioning, Ability to Access Services, and Client Satisfaction. 
Following the conclusion of assessments, the Intensive Case Management and Treatment As Usual groups will be compared on the above indicators, to determine whether intensive case management resulted in a reduction of suicide risk</outcome>
      <timepoint>These will be measured at 6 and 12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Improvements in life function</outcome>
      <timepoint>Measured at 6 and 12 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>History of suicide attempts and psychiatric illness are recruited at discharge from psychiatric inpatient setting at the Gold Coast Hospital.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>none</concealment>
    <sequence>simple alternate allocation (one/one)</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/03/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Griffith University</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Department of Health and Ageing</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>QLD Health</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Diego De Leo</name>
      <address>Australian Institute for Suicide Research and Prevention (AISRAP)
Griffith University
Mt Gravatt Campus
Nathan QLD 4111</address>
      <phone>+61 7 37353377</phone>
      <fax />
      <email>d.deleo@griffith.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Marianne Wyder</name>
      <address>Australian Institute for Suicide Research and Prevention (AISRAP)
Griffith University
Mt Gravatt Campus
Nathan QLD 4111</address>
      <phone>+61 7 37353380</phone>
      <fax />
      <email>m.wyder@griffith.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>